StockpollyBeta
Get App
Delisting riskPopularity #4,472
ASBP · NASDAQ · Biotechnology

Aspire Biopharma (ASBP)

Developer of sublingual drug and supplement formulations, including aspirin candidates and Buzz Bomb.

$8.20
After hours−0.01 (−0.17%)
At close$8.21(−5.80%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue000000000000
Cost of revenue000000000000
Gross profit000000000000
0030011611222
Research & development000000000000
0031011501212
Selling & marketing000000000000
General & administrative0031001501210
Other expenses000000000000
Operating income00−3−10−1−16−1−1−2−2−2
0000000−1−1−3−21
Interest income000000000000
Interest expense000000011620
Other non-operating income00000001−1000
Income before tax00−2−10−1−16−2−2−5−3−1
Income tax expense000000000000
Net income from continuing operations00−200−1−16−2−2−5−3−1
Net income00−2−10−1−16−2−2−5−3−1
EPS, basic−$0.11−$20.14−$0.27−$0.87−$0.19−$33.29−$16.83−$1.61−$1.49−$3.15−$2.16−$1.22
EPS, diluted−$0.11−$20.14−$0.27−$0.87−$0.19−$33.29−$16.83−$1.61−$1.49−$3.15−$2.16−$1.22
Weighted average shares, basic109110111111
Weighted average shares, diluted109110111111
EBITDA00−220−1−16−1240−2
Depreciation & amortization000000002620
EBIT00−220−1−16−10−2−2−2